483
Center for Translational MedicineCenter for Translational Medicine – FDA 483, Jul 11, 2025
Record Details
An FDA inspection of Center for Translational Medicine in Minneapolis, MN, a nonclinical laboratory, revealed significant deficiencies in their study conduct and record-keeping practices. The firm failed to adequately document study data, adhere to approved protocols, establish necessary standard operating procedures, maintain a comprehensive master schedule, and properly archive study records. These issues indicate a lack of robust quality control and data integrity.
View Company Profile
ID · f7bac46c-b8e0-4980-89f0-9442c1f9a8c7
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.